Blessing Tolulope Owolabi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Blessing Tolulope Owolabi has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Ayodeji Folorunsho Ajayi
Department of Physiology, Faculty of Basic Medical Sciences, Ladoke Akintola University of Technology, Ogbomoso, Nigeria
1 shared publication - Bisola Kemi Olaoye
Microbiology Unit, Department of Natural Science, Precious Cornerstone University, Ibadan 6576, Nigeria
1 shared publication - Blessing Oluwapelumi Oyebamiji
Department of Physiology, Faculty of Basic Medical Sciences, Ekiti State University, Ado-Ekiti, Ekiti State, Nigeria
1 shared publication - Elijah Olalekan Odesanmi
Department of Biochemistry, Ekiti State University, Nigeria
1 shared publication Gbenga Sunday Adeleye
1 shared publication- Kehinde Oluyemi Ajayi
Microbiology Unit, Department of Natural Science, Precious Cornerstone University, Ibadan 6576, Nigeria
1 shared publication
Latest Publications
- Open Access
- 25 May 2026
- Published by MDPI AG in Biology and Life Sciences Forum
- Vol. 62 (1) , 4
Bioactive Profiling of Citrus aurantium Peel Ethanol Extract and Effects on Escherichia coli and Staphylococcus aureus Drug Target Proteins
The rising threat of antimicrobial resistance necessitates the search for novel bioactive molecules from natural sources. This study investigated the phytochemical composition, antibacterial potency, and molecular docking interactions of Citrus aurantium peel ethanol extract against Escherichia coli outer-membrane and topoisomerase proteins and Staphylococcus aureus toxins as drug target proteins. Qualitative and quantitative phytochemical compositions were examined using standard analytical methods, chemical compounds were evaluated and qualified using Gas Chromatography–Mass Spectrometry (GC-MS), and antibacterial effects were investigated in silico and validated in vitro. Qualitative and quantitative analyses revealed high concentrations of flavonoids (4.54 ± 0.11%), alkaloids (1.6 ± 0.03%), terpenoids (1.35 ± 0.01%), tannins (1.02 ± 0.05%), phenols (0.97 ± 0.07%), and saponins (0.80 ± 0.01%). GC–MS profiling identified several dominant compounds, including β-D-glucopyranose, neo-inositol, 8-(2,3-dihydroxy-3-methylbutyl)-7-methoxy-2H-chromen-2-one, and D-allose. In silico docking studies against bacterial druggable proteins (PDB IDs: 4C56 and 3MFG, which are S. aureus toxins; 1BXW and 3FV5, which are E. coli outer-membrane and topoisomerase proteins) revealed strong binding affinities (−6.477 to −8.774 kcal/mol), comparable to standard antibiotics. ADMET predictions confirmed favorable pharmacokinetic and safety profiles, with most lead compounds displaying high intestinal absorption, low hepatotoxicity, and compliance with Lipinski’s rule of five. The extract exhibited stronger antibacterial activity, producing inhibition zones of 25.11 ± 0.017 and 23.04 ± 0.25 mm against clinical isolates of S. aureus and E. coli, respectively, at a concentration of 10 mg/mL, comparable to ciprofloxacin (30.35 ± 0.26 mm). These findings highlight C. aurantium peel phytoconstituents as promising scaffolds for antibacterial drug development and justify further in vivo validation for combating multidrug-resistant pathogens.
- 25 May 2026
- Published by MDPI AG in Biology and Life Sciences Forum
- Vol. 62 (1) , 4
Open AccessBioactive Profiling of Citrus aurantium Peel Ethanol Extract and Effects on Escherichia coli and Staphylococcus aureus Drug Target Proteins
The rising threat of antimicrobial resistance necessitates the search for novel bioactive molecules from natural sources. This study investigated the phytochemical composition, antibacterial potency, and molecular docking interactions of Citrus aurantium peel ethanol extract against Escherichia coli outer-membrane and topoisomerase proteins and Staphylococcus aureus toxins as drug target proteins. Qualitative and quantitative phytochemical compositions were examined using standard analytical methods, chemical compounds were evaluated and qualified using Gas Chromatography–Mass Spectrometry (GC-MS), and antibacterial effects were investigated in silico and validated in vitro. Qualitative and quantitative analyses revealed high concentrations of flavonoids (4.54 ± 0.11%), alkaloids (1.6 ± 0.03%), terpenoids (1.35 ± 0.01%), tannins (1.02 ± 0.05%), phenols (0.97 ± 0.07%), and saponins (0.80 ± 0.01%). GC–MS profiling identified several dominant compounds, including β-D-glucopyranose, neo-inositol, 8-(2,3-dihydroxy-3-methylbutyl)-7-methoxy-2H-chromen-2-one, and D-allose. In silico docking studies against bacterial druggable proteins (PDB IDs: 4C56 and 3MFG, which are S. aureus toxins; 1BXW and 3FV5, which are E. coli outer-membrane and topoisomerase proteins) revealed strong binding affinities (−6.477 to −8.774 kcal/mol), comparable to standard antibiotics. ADMET predictions confirmed favorable pharmacokinetic and safety profiles, with most lead compounds displaying high intestinal absorption, low hepatotoxicity, and compliance with Lipinski’s rule of five. The extract exhibited stronger antibacterial activity, producing inhibition zones of 25.11 ± 0.017 and 23.04 ± 0.25 mm against clinical isolates of S. aureus and E. coli, respectively, at a concentration of 10 mg/mL, comparable to ciprofloxacin (30.35 ± 0.26 mm). These findings highlight C. aurantium peel phytoconstituents as promising scaffolds for antibacterial drug development and justify further in vivo validation for combating multidrug-resistant pathogens.
- 7 December 2025
- Published by Australasia Publishing Group in Australian Journal of Biomedical Research
- Vol. 1 (2) , aubm011
Beetroot Fruit Powder Attenuates Cardiotoxicity Induced by Monosodium Glutamate via Inhibition of Oxidative Stress and Inflammation in Rats
Background: Cardiotoxicity, defined as damage to cardiac muscle resulting from exposure to toxic substances, is a growing concern in both environmental and medical contexts. Monosodium glutamate (MSG), a widely used food additive, has been implicated in cardiac toxicity through mechanisms involving inflammation, oxidative stress, and apoptosis. Beetroot (Beta vulgaris), rich in nitrates, betalains, and flavonoids, possesses strong antioxidant and anti-inflammatory properties that may counteract MSG-induced cardiac damage. Objective: This study investigated the cardioprotective potential of beetroot fruit powder (BFP) against MSG-induced cardiotoxicity in male Wistar rats by evaluating its effects on inflammatory, oxidative, apoptotic, cardiac functional markers, and DNA fragmentation index. Methods: Fifty male Wistar rats (185–205 g) were randomly divided into five groups: control, MSG-only, MSG + low-dose BFP (0.18 g/kg), MSG + high-dose BFP (0.36 g/kg), and MSG recovery group. MSG was administered orally (6 g/kg) for 21 days. BFP treatments were co-administered with MSG. On day 22, cardiac tissues were harvested and analyzed for inflammatory markers (MPO, NO, CRP, TNF-α, IL-1β, NF-κB), oxidative stress markers (MDA, SOD, CAT, GSH, GPx, GST), cardiac enzymes (LDH, SDH, CK, GGT), caspase-3 activity, and DNA fragmentation (TUNEL assay). Histological examination was also performed. Results: MSG exposure significantly elevated pro-inflammatory cytokines, oxidative stress, caspase-3 activity, and cardiac dysfunction markers, alongside pronounced DNA fragmentation and histological alterations. BFP co-treatment, particularly at the high dose, significantly attenuated these changes by reducing pro-inflammatory markers, restoring antioxidant enzyme levels, normalizing cardiac enzyme activities, and lowering DNA fragmentation index. Histology confirmed structural recovery of cardiac tissue in BFP-treated groups. These results underscore the potential of BFP as a dietary intervention to mitigate chemically induced myocardial injury. While the MSG dose used exceeds typical human exposure, this model provides valuable mechanistic insights. Future studies should explore chronic, lower-dose MSG exposure, gene-level regulatory mechanisms, and translational trials in humans. Conclusion: Beetroot fruit powder demonstrates a potent cardioprotective effect against MSG-induced toxicity by modulating oxidative, inflammatory, apoptotic, and functional biomarkers. These findings highlight its potential as a natural therapeutic agent for mitigating chemically-induced cardiac injury.
- 7 December 2025
- Published by Australasia Publishing Group in Australian Journal of Biomedical Research
- Vol. 1 (2) , aubm011
Beetroot Fruit Powder Attenuates Cardiotoxicity Induced by Monosodium Glutamate via Inhibition of Oxidative Stress and Inflammation in Rats
Background: Cardiotoxicity, defined as damage to cardiac muscle resulting from exposure to toxic substances, is a growing concern in both environmental and medical contexts. Monosodium glutamate (MSG), a widely used food additive, has been implicated in cardiac toxicity through mechanisms involving inflammation, oxidative stress, and apoptosis. Beetroot (Beta vulgaris), rich in nitrates, betalains, and flavonoids, possesses strong antioxidant and anti-inflammatory properties that may counteract MSG-induced cardiac damage. Objective: This study investigated the cardioprotective potential of beetroot fruit powder (BFP) against MSG-induced cardiotoxicity in male Wistar rats by evaluating its effects on inflammatory, oxidative, apoptotic, cardiac functional markers, and DNA fragmentation index. Methods: Fifty male Wistar rats (185–205 g) were randomly divided into five groups: control, MSG-only, MSG + low-dose BFP (0.18 g/kg), MSG + high-dose BFP (0.36 g/kg), and MSG recovery group. MSG was administered orally (6 g/kg) for 21 days. BFP treatments were co-administered with MSG. On day 22, cardiac tissues were harvested and analyzed for inflammatory markers (MPO, NO, CRP, TNF-α, IL-1β, NF-κB), oxidative stress markers (MDA, SOD, CAT, GSH, GPx, GST), cardiac enzymes (LDH, SDH, CK, GGT), caspase-3 activity, and DNA fragmentation (TUNEL assay). Histological examination was also performed. Results: MSG exposure significantly elevated pro-inflammatory cytokines, oxidative stress, caspase-3 activity, and cardiac dysfunction markers, alongside pronounced DNA fragmentation and histological alterations. BFP co-treatment, particularly at the high dose, significantly attenuated these changes by reducing pro-inflammatory markers, restoring antioxidant enzyme levels, normalizing cardiac enzyme activities, and lowering DNA fragmentation index. Histology confirmed structural recovery of cardiac tissue in BFP-treated groups. These results underscore the potential of BFP as a dietary intervention to mitigate chemically induced myocardial injury. While the MSG dose used exceeds typical human exposure, this model provides valuable mechanistic insights. Future studies should explore chronic, lower-dose MSG exposure, gene-level regulatory mechanisms, and translational trials in humans. Conclusion: Beetroot fruit powder demonstrates a potent cardioprotective effect against MSG-induced toxicity by modulating oxidative, inflammatory, apoptotic, and functional biomarkers. These findings highlight its potential as a natural therapeutic agent for mitigating chemically-induced cardiac injury.